154 related articles for article (PubMed ID: 37704773)
1. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study.
Gupta M; Rumman M; Singh B; Mahdi AA; Pandey S
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1647-1658. PubMed ID: 37704773
[TBL] [Abstract][Full Text] [Related]
2. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis.
Xia X; Yan J; Shen Y; Tang K; Yin J; Zhang Y; Yang D; Liang H; Ye J; Weng J
PLoS One; 2011 Feb; 6(2):e16556. PubMed ID: 21304897
[TBL] [Abstract][Full Text] [Related]
3. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.
Chen Y; Li Q; Zhao S; Sun L; Yin Z; Wang X; Li X; Iwakiri Y; Han J; Duan Y
Biochem Pharmacol; 2023 Dec; 218():115928. PubMed ID: 37979703
[TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice.
Li M; Dang Y; Li Q; Zhou W; Zuo J; Yao Z; Zhang L; Ji G
Sci Rep; 2019 May; 9(1):8003. PubMed ID: 31142783
[TBL] [Abstract][Full Text] [Related]
5. In silico network pharmacology and in vivo analysis of berberine-related mechanisms against type 2 diabetes mellitus and its complications.
Di S; Han L; An X; Kong R; Gao Z; Yang Y; Wang X; Zhang P; Ding Q; Wu H; Wang H; Zhao L; Tong X
J Ethnopharmacol; 2021 Aug; 276():114180. PubMed ID: 33957209
[TBL] [Abstract][Full Text] [Related]
6. Berberine Attenuates Hyperglycemia by Inhibiting the Hepatic Glucagon Pathway in Diabetic Mice.
Zhong Y; Jin J; Liu P; Song Y; Zhang H; Sheng L; Zhou H; Jiang B
Oxid Med Cell Longev; 2020; 2020():6210526. PubMed ID: 31976031
[TBL] [Abstract][Full Text] [Related]
7. Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.
Wei S; Zhang M; Yu Y; Lan X; Yao F; Yan X; Chen L; Hatch GM
PLoS One; 2016; 11(3):e0152097. PubMed ID: 27011261
[TBL] [Abstract][Full Text] [Related]
8. Berberine promotes peri-implant osteogenesis in diabetic rats by ROS-mediated IRS-1 pathway.
Shao J; Liu S; Zheng X; Chen J; Li L; Zhu Z
Biofactors; 2021 Jan; 47(1):80-92. PubMed ID: 33233028
[TBL] [Abstract][Full Text] [Related]
9. Berberine Improves Inflammatory Responses of Diabetes Mellitus in Zucker Diabetic Fatty Rats and Insulin-Resistant HepG2 Cells through the PPM1B Pathway.
Wu YS; Li ZM; Chen YT; Dai SJ; Zhou XJ; Yang YX; Lou JS; Ji LT; Bao YT; Xuan L; Lin LN; Li CY
J Immunol Res; 2020; 2020():2141508. PubMed ID: 32908938
[TBL] [Abstract][Full Text] [Related]
10. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
11. Combination of metformin and berberine represses the apoptosis of sebocytes in high-fat diet-induced diabetic hamsters and an insulin-treated human cell line.
Yao Y; Zuo J; Chen L; Wei Y
Cell Biochem Funct; 2020 Jul; 38(5):567-573. PubMed ID: 32080865
[TBL] [Abstract][Full Text] [Related]
12. Berberine improves kidney function in diabetic mice via AMPK activation.
Zhao L; Sun LN; Nie HB; Wang XL; Guan GJ
PLoS One; 2014; 9(11):e113398. PubMed ID: 25409232
[TBL] [Abstract][Full Text] [Related]
13. Exploring the synergistic and complementary effects of berberine and paeoniflorin in the treatment of type 2 diabetes mellitus by network pharmacology.
Zhang L; Han L; Ma J; Wu T; Wei Y; Zhao L; Tong X
Eur J Pharmacol; 2022 Mar; 919():174769. PubMed ID: 35151646
[TBL] [Abstract][Full Text] [Related]
14. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA
Li J; Du H; Zhang M; Zhang Z; Teng F; Zhao Y; Zhang W; Yu Y; Feng L; Cui X; Zhang M; Lu T; Guan F; Chen L
Int J Biol Sci; 2019; 15(7):1533-1545. PubMed ID: 31337982
[No Abstract] [Full Text] [Related]
15. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
Wang Y; Campbell T; Perry B; Beaurepaire C; Qin L
Metabolism; 2011 Feb; 60(2):298-305. PubMed ID: 20304443
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anti-inflammatory effects of berberine, and its natural oxidative and reduced derivatives from Rhizoma Coptidis in vitro and in vivo.
Li CL; Tan LH; Wang YF; Luo CD; Chen HB; Lu Q; Li YC; Yang XB; Chen JN; Liu YH; Xie JH; Su ZR
Phytomedicine; 2019 Jan; 52():272-283. PubMed ID: 30599908
[TBL] [Abstract][Full Text] [Related]
17. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
Yao Y; Chen H; Yan L; Wang W; Wang D
Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
[TBL] [Abstract][Full Text] [Related]
18. The Hypoglycemic Effect of Berberine and Berberrubine Involves Modulation of Intestinal Farnesoid X Receptor Signaling Pathway and Inhibition of Hepatic Gluconeogenesis.
Sun R; Kong B; Yang N; Cao B; Feng D; Yu X; Ge C; Feng S; Fei F; Huang J; Lu Z; Xie Y; Yang CS; Guo GL; Wang G; Aa J
Drug Metab Dispos; 2021 Mar; 49(3):276-286. PubMed ID: 33376148
[TBL] [Abstract][Full Text] [Related]
19. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
[TBL] [Abstract][Full Text] [Related]
20. Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice.
Yang G; Zhao Z; Zhang X; Wu A; Huang Y; Miao Y; Yang M
Drug Des Devel Ther; 2017; 11():1065-1079. PubMed ID: 28408805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
